Segment Information

6 Months Ended

Jul. 01, 2011

Segment Information

Segment Information

NOTE 11. SEGMENT INFORMATION

During the fourth quarter of 2010, the Company changed the composition of its reportable segments to reflect changes in its internal organization resulting from the rate of growth within certain of the Company's businesses and the contribution of certain of the Company's tool manufacturing and distribution businesses to the Apex joint venture. The Company now reports results in five separate business segments consisting of the Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental; and Industrial Technologies segments. In addition, the historical results of the tool related business and the Company's equity in earnings of the Apex joint venture is shown separately in the Company's segment disclosures. The Company previously reported its operations under four segments: Professional Instrumentation; Medical Technologies; Industrial Technologies; and Tools & Components. There has been no material change in total assets or liabilities by segment since December 31, 2010, except for the addition of Beckman Coulter, Inc. to the Life Sciences & Diagnostics segment effective June 25, 2011 and the sale of the Pacific Scientific Aerospace business from the Industrial Technologies segment in April 2011. Segment results for the three and six months ended July 1, 2011 and July 2, 2010 are shown below ($ in millions):

	Three Months Ended						Six Months Ended
	July 1, 2011			July 2, 2010			July 1, 2011			July 2, 2010
Sales:
Test & Measurement	$	848.2		$	682.2		$	1,678.7		$	1,334.3
Environmental		730.6			696.0			1,398.6			1,307.7
Life Sciences & Diagnostics		704.8			540.1			1,331.4			1,056.6
Dental		504.7			428.3			968.2			860.1
Industrial Technologies		923.4			698.5			1,680.5			1,351.0
Businesses contributed to Apex joint venture attributable to periods prior to contribution		—			172.3			—			315.6
	$	3,711.7		$	3,217.4		$	7,057.4		$	6,225.3
Operating Profit:
Test & Measurement	$	190.2		$	145.3		$	362.4		$	269.1
Environmental		158.4			150.6			287.3			254.6
Life Sciences & Diagnostics		34.5			32.4			124.9			69.2
Dental		55.0			46.2			104.5			82.8
Industrial Technologies		200.5			144.8			362.1			270.0
Businesses contributed to Apex joint venture:
Attributable to period prior to contribution		—			22.7			—			41.5
Equity method earnings subsequent to JV formation		14.5			—			28.9			—
Other		(27.0	)		(24.2	)		(53.4	)		(47.9	)
	$	626.1		$	517.8		$	1,216.7		$	939.3